https://www.biospace.com/bavarian-nordic-initiates-rolling-submission-of-biologics-license-application-with-fda-for-its-chikungunya-vaccine-candidate
Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a...
biologics license applicationbavarian nordicinitiatesrollingsubmission
https://www.telegraphindia.com/world/world-health-organization-approves-bavarian-nordics-mpox-vaccine-for-adolescents/cid/2055372
The WHO said in a statement that it gave the Jynneos vaccine prequalification for adolescents on October 8
world health organizationbavarian nordic
https://www.hl.co.uk/shares/shares-search-results/b/bavarian-nordic-research-institute-dkk10/dividends
View Bavarian Nordic Research Institute DKK10 dividend dates and history including final, interim and special dividends. Plus growth, cover and dividend yield.
dividend paymentsbavarian nordicresearch institutehistorydates
https://www.pharmaceutical-technology.com/news/bavarian-nordic-chikungunya-vaccine/
The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.
bavarian nordicchikungunya virusmhravaccine
https://www.pharmaceutical-technology.com/analyst-comment/monkeypox-vaccine-eua/
Monkeypox was declared a public health emergency and the FDA granted a EUA for the Bavarian Nordic monkeypox vaccine.
monkeypox vaccinebavarian nordicfirsteuaamid
https://www.pharmaceutical-technology.com/news/ec-bavarian-nordic-vaccine/
The EC has authorised the marketing of Bavarian Nordic's Vimkunya chikungunya vaccine for individuals as young as 12 years old.
bavarian nordicchikungunya vaccineecmarketing
https://www.business-standard.com/health/one-bavarian-nordic-smallpox-shot-58-effective-against-mpox-study-shows-124091200096_1.html
One vaccination provided about 58 per cent protection against Mpox infection, researchers found in the study
bavarian nordiconesmallpoxshoteffective
https://cyprus-mail.com/2022/07/25/bavarian-nordic-monkeypox-vaccine-wins-eu-approval
Danish biotechnology company Bavarian Nordic BAVA.CO said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as...
bavarian nordicmonkeypox vaccinecyprus mailwinseu
https://www.pharmaceutical-technology.com/news/bavarian-nordic-shares-rise-7-following-strong-q1-for-vaccine-sales/
Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from Q1 2024.
bavarian nordicsharesrisefollowingstrong